{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T21:52:09Z","timestamp":1768341129788,"version":"3.49.0"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T00:00:00Z","timestamp":1651104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Interstitial cystitis (IC)\/bladder pain syndrome (BPS) is a chronic bladder disease of unknown etiology characterized by urinary frequency and episodic and chronic pain. Analgesic treatments for IC\/BPS are limited, especially for patients with non-Hunner (non-ulcerative) type IC who usually have poor overall outcomes. Here, we demonstrate that oral treatment with DF2755A, a potent and selective inhibitor of chemokine receptors CXCR1\/2, can prevent and reverse peripheral neuropathy associated to non-Hunner IC\/BPS by directly inhibiting chemokine-induced excitation of sensory neurons. We tested DF2755A antinociceptive effects in a cyclophosphamide (CYP)-induced non-ulcerative IC rat model characterized by severe peripheral neuropathy in the absence of bladder inflammatory infiltrate, urothelial hyperplasia, and hemorrhage. Treatment with DF2755A prevented the onset of peripheral neuropathy and reversed its development in CYP-induced IC rats, showing a strong and long-lasting anti-hyperalgesic effect. <jats:italic>Ex vivo<\/jats:italic> and <jats:italic>in vitro<\/jats:italic> studies showed that DF2755A treatment strongly inhibited the expression of CXCR2 agonists, CXCL1\/KC, and CXCL5 and of transient receptor potential vanilloid 1 (TRPV1) compared to vehicle, suggesting that its effects can be due to the inhibition of the nociceptive signaling passing through the CXCL1\/CXCR1-2 axis and TRPV1. In conclusion, our results highlight the key pathophysiological role played by the CXCL1\/CXCR1-2 axis and TRPV1 in the onset and development of peripheral neuropathy in non-Hunner IC and propose DF2755A as a potential therapeutic approach for the treatment of not only inflammatory painful conditions but also neuropathic ones and in particular non-Hunner IC\/BPS.<\/jats:p>","DOI":"10.3389\/fphar.2022.854238","type":"journal-article","created":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T08:51:00Z","timestamp":1651135860000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Inflammation-Independent Antinociceptive Effects of DF2755A, a CXCR1\/2 Selective Inhibitor: A New Potential Therapeutic Treatment for Peripheral Neuropathy Associated to Non-Ulcerative Interstitial Cystitis\/Bladder Pain Syndrome"],"prefix":"10.3389","volume":"13","author":[{"given":"Laura","family":"Brandolini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Aramini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianluca","family":"Bianchini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Ruocco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Bertini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rubina","family":"Novelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Angelico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Elisa","family":"Valsecchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Castelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annamaria","family":"Cimini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcello","family":"Allegretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"F589","DOI":"10.1152\/ajprenal.00628.2009","article-title":"Expression and Function of CXCL12\/CXCR4 in Rat Urinary Bladder with Cyclophosphamide-Induced Cystitis","volume":"298","author":"Arms","year":"2010","journal-title":"Am. J. Physiol. Ren. Physiol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ejphar.2013.03.008","article-title":"Relevance of the Cyclophosphamide-Induced Cystitis Model for Pharmacological Studies Targeting Inflammation and Pain of the Bladder","volume":"707","author":"Aug\u00e9","year":"2013","journal-title":"Eur J. Pharmacol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.3389\/fphar.2020.01305","article-title":"Characterization and Validation of a Chronic Model of Cyclophosphamide-Induced Interstitial Cystitis\/Bladder Pain Syndrome in Rats","volume":"11","author":"Aug\u00e9","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3389\/fpain.2021.642706","article-title":"Pain Management in a Model of Interstitial Cystitis\/Bladder Pain Syndrome by a Vaccinal Strategy","volume":"2","author":"Aug\u00e9","year":"2021","journal-title":"Front. Pain Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/nrd3845","article-title":"Reducing Safety-Related Drug Attrition: The Use of In Vitro Pharmacological Profiling","volume":"11","author":"Bowes","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"B5","doi-asserted-by":"publisher","first-page":"23188","DOI":"10.18632\/oncotarget.15533","article-title":"CXCR1\/2 Pathways in Paclitaxel-Induced Neuropathic Pain","volume":"8","author":"Brandolini","year":"2017","journal-title":"Oncotarget"},{"key":"B48","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.brainresbull.2016.09.016","article-title":"Chemokine Receptor CXCR2 in Dorsal Root Ganglion Contributes to the Maintenance of Inflammatory Pain","volume":"127","author":"Cao","year":"2016","journal-title":"Brain Res. Bull."},{"key":"B47","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.expneurol.2014.05.014","article-title":"Chemokine CXCL1 Enhances Inflammatory Pain and Increases NMDA Receptor Activity and COX-2 Expression in Spinal Cord Neurons via Activation of CXCR2","volume":"261","author":"Cao","year":"2014","journal-title":"Exp. Neurol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1002\/j.1532-2149.2012.00240.x","article-title":"Neutrophils Recruited by CXCR1\/2 Signalling Mediate Post-Incisional Pain","volume":"17","author":"Carreira","year":"2013","journal-title":"Eur. J. Pain"},{"key":"B7","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/nrneurol.2010.16010.1016\/j.ejca.2009.12.008","article-title":"Chemotherapy-Induced Peripheral Neurotoxicity Assessment: a Critical Revision of the Currently Available Tools","volume":"46","author":"Cavaletti","year":"2010","journal-title":"Eur. J. Cancer"},{"key":"B8","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12974-020-01786-5","article-title":"Normalization of Magnesium Deficiency Attenuated Mechanical Allodynia, Depressive-like Behaviors, and Memory Deficits Associated with Cyclophosphamide-Induced Cystitis by Inhibiting TNF-\u0391\/nf-\u039ab Signaling in Female Rats","volume":"17","author":"Chen","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"B9","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/01.ju.0000146114.53828.82","article-title":"Prevalence and Incidence of Interstitial Cystitis in a Managed Care Population","volume":"173","author":"Clemens","year":"2005","journal-title":"J. Urol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"14841","DOI":"10.1021\/acsomega.8b02273","article-title":"1,3-Dibromo-1,1-Difluoro-2-Propanone as a Useful Synthon for a Chemoselective Preparation of 4-Bromodifluoromethyl Thiazoles","volume":"3","author":"Colella","year":"2018","journal-title":"ACS Omega"},{"key":"B44","article-title":"Alkylating Agents","volume-title":"Holland-Frei Cancer Medicine","author":"Colvin","year":"2003"},{"key":"B11","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/bjp.2008.94","article-title":"Treatment with DF 2162, a Non-competitive Allosteric Inhibitor of CXCR1\/2, Diminishes Neutrophil Influx and Inflammatory Hypernociception in Mice","volume":"154","author":"Cunha","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/bph.12467","article-title":"Role of CXCR2 and TRPV1 in Functional, Inflammatory and Behavioural Changes in the Rat Model of Cyclophosphamide-Induced Haemorrhagic Cystitis","volume":"171","author":"Dornelles","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3978\/j.issn.2223-4683.2015.10.09","article-title":"Similarities Between Interstitial Cystitis\/Bladder Pain Syndrome and Vulvodynia: Implications for Patient Management","volume":"4","author":"Fariello","year":"2015","journal-title":"Transl. Androl. Urol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"120525","DOI":"10.1155\/2014\/120525","article-title":"The Role(s) of Cytokines\/Chemokines in Urinary Bladder Inflammation and Dysfunction","volume":"2014","author":"Gonzalez","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"B13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ejphar.2011.10.023","article-title":"Toll-like Receptor 2\/MyD88 Signaling Mediates Zymosan-Induced Joint Hypernociception in Mice: Participation of TNF-\u03b1, IL-1\u03b2 and CXCL1\/KC","volume":"674","author":"Guerrero","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"611","DOI":"10.3978\/j.issn.2223-4683.2015.10.10","article-title":"A Multidisciplinary Approach to the Evaluation and Management of Interstitial Cystitis\/Bladder Pain Syndrome: An Ideal Model of Care","volume":"4","author":"Gupta","year":"2015","journal-title":"Transl Androl. Urol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3389\/fncel.2020.00184","article-title":"Immortalized Dorsal Root Ganglion Neuron Cell Lines","volume":"14","author":"Haberberger","year":"2020","journal-title":"Front Cel Neurosci"},{"key":"B50","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.1111\/febs.14466","article-title":"A Guide to Chemokines and Their Receptors","volume":"285","author":"Hughes","year":"2018","journal-title":"FEBS J."},{"key":"B45","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3390\/pr9020377","article-title":"Evolution of Nitrogen-Based Alkylating Anticancer Agents","volume":"9","author":"Lehmann","year":"2021","journal-title":"Processes"},{"key":"B16","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.phrs.2015.11.005","article-title":"DF2755A, a Novel Non-competitive Allosteric Inhibitor of CXCR1\/2, Reduces Inflammatory and Post-Operative Pain","volume":"103","author":"Lopes","year":"2016","journal-title":"Pharmacol. Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1046\/j.1526-4637.2001.002001060.x","article-title":"Interstitial Cystitis and Pelvic Floor Dysfunction: A Comprehensive Review","volume":"2","author":"Lukban","year":"2001","journal-title":"Pain Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"117590","DOI":"10.1016\/j.lfs.2020.117590","article-title":"Chlorogenic Acid Attenuates Cyclophosphamide-Induced Rat Interstitial Cystitis","volume":"254","author":"Luo","year":"2020","journal-title":"Life Sci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"e0143316","DOI":"10.1371\/journal.pone.0143316","article-title":"Hunner-Type (Classic) Interstitial Cystitis: A Distinct Inflammatory Disorder Characterized by Pancystitis, with Frequent Expansion of Clonal B-Cells and Epithelial Denudation","volume":"10","author":"Maeda","year":"2015","journal-title":"PLoS One"},{"key":"B18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.neuropharm.2013.10.026","article-title":"The Role of Keratinocyte-Derived Chemokine (KC) on Hyperalgesia Caused by Peripheral Nerve Injury in Mice","volume":"79","author":"Manjavachi","year":"2014","journal-title":"Neuropharmacology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/BF01213547","article-title":"Chemotherapy-Associated Neurotoxicity: An Important Side Effect-Impacting on Quality, rather Than Quantity, of Life","volume":"122","author":"Markman","year":"1996","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1016\/j.juro.2009.11.007","article-title":"CXCR3 Binding Chemokine and TNFSF14 Over Expression in Bladder Urothelium of Patients with Ulcerative Interstitial Cystitis","volume":"183","author":"Ogawa","year":"2010","journal-title":"J. Urol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"5027","DOI":"10.1523\/JNEUROSCI.21-14-05027.2001","article-title":"Chemokines and Glycoprotein120 Produce Pain Hypersensitivity by Directly Exciting Primary Nociceptive Neurons","volume":"21","author":"Oh","year":"2001","journal-title":"J. Neurosci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/s0022-5347(05)64910-5","article-title":"Topography of the Vanilloid Receptor in the Human Bladder: More Than Just the Nerve Fibers","volume":"168","author":"Ost","year":"2002","journal-title":"J. Urol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1007\/s00404-017-4364-2","article-title":"Etiology, Pathophysiology and Biomarkers of Interstitial Cystitis\/Painful Bladder Syndrome","volume":"295","author":"Patnaik","year":"2017","journal-title":"Arch. Gynecol. Obstet."},{"key":"B53","doi-asserted-by":"publisher","first-page":"e3000410","DOI":"10.1371\/journal.pbio.3000410","article-title":"The ARRIVE Guidelines 2.0: Updated Guidelines for Reporting Animal Research","volume":"18","author":"Percie du Sert","year":"2020","journal-title":"PLoS Biol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.3389\/fimmu.2019.02198","article-title":"Pharmacological Blockade of Spinal CXCL3\/CXCR2 Signaling by NVP CXCR2 20, a Selective CXCR2 Antagonist, Reduces Neuropathic Pain Following Peripheral Nerve Injury","volume":"10","author":"Piotrowska","year":"2019","journal-title":"Front. Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1073\/pnas.82.10.3499","article-title":"Neuronal Traits of Clonal Cell Lines Derived by Fusion of Dorsal Root Ganglia Neurons with Neuroblastoma Cells","volume":"82","author":"Platika","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"B24","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/jnr.20612","article-title":"CCL2 and CXCL1 Trigger Calcitonin Gene-Related Peptide Release by Exciting Primary Nociceptive Neurons","volume":"82","author":"Qin","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1476-8518-6-6","article-title":"CXCL10 Blockade Protects Mice from Cyclophosphamide-Induced Cystitis","volume":"6","author":"Sakthivel","year":"2008","journal-title":"J. Immune Based Ther. Vaccin."},{"key":"B26","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.nbd.2017.06.001","article-title":"CXCL1\/CXCR2 Signaling in Pathological Pain: Role in Peripheral and Central Sensitization","volume":"105","author":"Silva","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.urology.2008.07.031","article-title":"Multiplex Analysis of Urinary Cytokine Levels in Rat Model of Cyclophosphamide-Induced Cystitis","volume":"73","author":"Smaldone","year":"2009","journal-title":"Urology"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1152\/jn.00222.2006","article-title":"MCP-1 Enhances Excitability of Nociceptive Neurons in Chronically Compressed Dorsal Root Ganglia","volume":"96","author":"Sun","year":"2006","journal-title":"J. Neurophysiol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1016\/j.juro.2012.01.034","article-title":"Urinary Chemokines as Noninvasive Predictors of Ulcerative Interstitial Cystitis","volume":"187","author":"Tyagi","year":"2012","journal-title":"J. Urol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"350","DOI":"10.4103\/0970-1591.128513","article-title":"Treatment of Interstitial Cystitis\/Painful Bladder Syndrome as a Neuropathic Pain Condition","volume":"30","author":"Vas","year":"2014","journal-title":"Indian J Urol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ajur.2016.08.014","article-title":"Addressing Quality of Life in the Patient with Interstitial Cystitis\/Bladder Pain Syndrome","volume":"4","author":"Vasudevan","year":"2017","journal-title":"Asian J. Urol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e3898","DOI":"10.1371\/journal.pone.0003898","article-title":"Cyclophosphamide-Induced Cystitis Increases Bladder CXCR4 Expression and CXCR4-Macrophage Migration Inhibitory Factor Association","volume":"3","author":"Vera","year":"2008","journal-title":"PLoS One"},{"key":"B30","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.pharmthera.2006.04.001","article-title":"Hypernociceptive Role of Cytokines and Chemokines: Targets for Analgesic Drug Development?","volume":"112","author":"Verri","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"B31","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/(sici)1096-9861(19960624)370:2<191::aid-cne5>3.0.co;2-y","article-title":"Increased Expression of Neuronal Nitric Oxide Synthase in Bladder Afferent Pathways Following Chronic Bladder Irritation","volume":"370","author":"Vizzard","year":"1996","journal-title":"J. Comp. Neurol."},{"key":"B54","first-page":"147","article-title":"The Ullberg Technique of Whole Body Autoradiography","volume":"35","author":"Waddell","year":"1967","journal-title":"J. Biol. Photogr. Assoc."},{"key":"B32","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1744-8069-4-38","article-title":"The Chemokine CXCL1\/Growth Related Oncogene Increases Sodium Currents and Neuronal Excitability in Small Diameter Sensory Neurons","volume":"4","author":"Wang","year":"","journal-title":"Mol. Pain"},{"key":"B33","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.pain.2008.03.020","article-title":"Lack of TRPV1 Inhibits Cystitis-Induced Increased Mechanical Sensitivity in Mice","volume":"139","author":"Wang","year":"","journal-title":"Pain"},{"key":"B34","doi-asserted-by":"publisher","first-page":"20151","DOI":"10.1073\/pnas.0709250104","article-title":"Chemokines and the Pathophysiology of Neuropathic Pain","volume":"104","author":"White","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"B35","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/iju.13971","article-title":"Hunner Lesion versus Non-hunner Lesion Interstitial Cystitis\/Bladder Pain Syndrome","volume":"26","author":"Whitmore","year":"2019","journal-title":"Int. J. Urol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.autneu.2006.02.030","article-title":"Expression of Fractalkine and Fractalkine Receptor in Urinary Bladder after Cyclophosphamide (CYP)-Induced Cystitis","author":"Yuridullah","year":"2006","journal-title":"Auton. Neurosci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1016\/j.pain.2013.07.002","article-title":"Chemokine Contribution to Neuropathic Pain: Respective Induction of CXCL1 and CXCR2 in Spinal Cord Astrocytes and Neurons","volume":"154","author":"Zhang","year":"2013","journal-title":"Pain"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.854238\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T08:51:06Z","timestamp":1651135866000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.854238\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,28]]},"references-count":54,"alternative-id":["10.3389\/fphar.2022.854238"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.854238","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,28]]},"article-number":"854238"}}